5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.56▲ | 3.55▲ | 3.57▼ | 3.71▼ | 3.21▲ |
MA10 | 3.54▲ | 3.58▼ | 3.60▼ | 3.65▼ | 2.71▲ |
MA20 | 3.54▲ | 3.61▼ | 3.62▼ | 3.26▲ | 2.36▲ |
MA50 | 3.58▼ | 3.68▼ | 3.75▼ | 2.60▲ | 1.91▲ |
MA100 | 3.60▼ | 3.74▼ | 3.44▲ | 2.33▲ | 1.60▲ |
MA200 | 3.63▼ | 3.39▲ | 3.02▲ | 2.01▲ | 1.40▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | -0.004▼ | -0.009▼ | 0.007▲ | 0.158▲ |
RSI | 52.899▲ | 41.440▼ | 41.281▼ | 62.711▲ | 69.470▲ |
STOCH | 83.712▲ | 16.483▼ | 25.923 | 69.798 | 86.114▲ |
WILL %R | -9.091▲ | -73.684 | -73.684 | -42.425 | -20.182▲ |
CCI | 88.148 | -85.810 | -115.880▼ | 32.237 | 169.560▲ |
CDL | $AKBA Doji Candlestick Pattern Detected | Set Alert |
Sunday, June 08, 2025 05:00 PM
Richard C Malabre, the SVP of $AKBA, sold 15,000 shares of the company on 06-09-2025 for an estimated $60,150. We received data on the trade from a recent SEC filing ...
|
Saturday, June 07, 2025 08:36 PM
Akebia Therapeutics' Vafseo expansion may boost future growth despite Auryxia's exclusivity loss. Read why AKBA stock is rated a hold.
|
Thursday, June 05, 2025 01:33 PM
Matthew Caufield, an analyst from H.C. Wainwright, initiated coverage of Akebia Therapeutics, Inc. (NASDAQ:AKBA) with a Buy rating and a $8 price target, on June 4. The analyst gave the optimistic ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 3.585 | 3.70 | 3.51 | 3.56 | 6,476,437 |
12/06/25 | 3.51 | 3.70 | 3.49 | 3.65 | 4,113,664 |
11/06/25 | 3.98 | 3.98 | 3.56 | 3.57 | 7,000,130 |
10/06/25 | 3.775 | 3.925 | 3.49 | 3.915 | 11,037,205 |
09/06/25 | 4.04 | 4.0758 | 3.83 | 3.83 | 8,127,015 |
06/06/25 | 3.66 | 4.00 | 3.66 | 3.97 | 8,184,564 |
05/06/25 | 3.69 | 3.7299 | 3.52 | 3.69 | 5,742,346 |
04/06/25 | 3.44 | 3.73 | 3.42 | 3.64 | 12,190,851 |
03/06/25 | 3.30 | 3.49 | 3.22 | 3.42 | 7,159,401 |
02/06/25 | 3.06 | 3.26 | 2.97 | 3.25 | 8,642,552 |
|
|
||||
|
|
||||
|
|